로딩 중…
지수 로딩 중…
OSTEONIC Co., Ltd.
226400· KOSDAQ· Health Care· Health Care Equipment & Services
₩4,070+0.25%
2026-11-02
Financials
Valuation Metrics
OSTEONIC Co., Ltd.'s Market Cap is ₩845B. At end of 2025 it was ₩1292B. Ranked #1340 of 2,410 in KR market (top 56%), #744 of 1,631 on KOSDAQ (top 46%), #49 of 94 in Health Care Equipment & Services (top 52%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 84.53B KRW | KR#1,340/2,410 Sec#49/94 |
| Revenue | 50.97B KRW | KR#1,775/2,410 Sec#52/94 |
| Net Income | 10.20B KRW | KR#965/2,410 Sec#25/94 |
| Total Assets | 113.71B KRW | KR#1,678/2,410 Sec#50/94 |
| Net Assets | 72.05B KRW | KR#1,665/2,410 Sec#51/94 |
| Employees | 179 | KR#1,171/2,410 Sec#35/94 |
| Value | ||
| P/E | 8.29x | KR#734/2,410 Sec#20/94 |
| P/B | 1.17x | KR#1,668/2,410 Sec#51/94 |
| PEG | 0.11x | KR#447/2,410 Sec#20/94 |
| P/S | 1.66x | KR#1,754/2,410 Sec#46/94 |
| EV/EBITDA | 9.55x | KR#628/2,410 Sec#21/94 |
| FCF Yield | 0.38% | KR#1,188/2,410 Sec#32/94 |
| Profitability | ||
| ROE | 14.16% | KR#361/2,410 Sec#12/94 |
| ROA | 8.97% | KR#348/2,410 Sec#18/94 |
| Op. Margin | 18.38% | KR#195/2,410 Sec#17/94 |
| Revenue Growth | 32.74% | KR#354/2,410 Sec#18/94 |
| Earnings Growth | 77.20% | KR#445/2,410 Sec#22/94 |
| Financial Health | ||
| Debt Ratio | 57.82% | KR#1,065/2,410 Sec#60/94 |
| Total Debt | 19.26B KRW | KR#1,387/2,410 Sec#40/94 |
| FCF | 323.6M KRW | KR#1,199/2,410 Sec#33/94 |
| Cash | 14.29B KRW | KR#1,463/2,410 Sec#43/94 |
| Current Ratio | 2.27x | KR#763/2,410 Sec#44/94 |
| Net Debt/EBITDA | 0.53x | KR#679/2,410 Sec#28/94 |
| Performance | ||
| 1Y Return | -43.47% | KR#1,840/2,410 Sec#65/94 |
| 1M Return | -2.28% | KR#474/2,410 Sec#16/94 |
| From 52W High | -47.42% | KR#1,052/2,410 Sec#37/94 |
| 1Y MDD | -50.98% | KR#998/2,410 Sec#37/94 |
| Trading | ||
| Volume | 31,386 shares | KR#1,042/2,410 Sec#39/94 |
| Trading Value | 127.2M KRW | KR#1,217/2,410 Sec#50/94 |
| Foreign Own. | 6.26% | KR#704/2,410 Sec#19/94 |
| Per Share | ||
| EPS | 491 KRW | KR#1,006/2,410 Sec#26/94 |
| BPS | 3,469 KRW | KR#1,771/2,410 Sec#49/94 |
Company Info
Osteonick, established in 2012, specializes in the development, manufacturing, and sale of orthopedic implants, and was listed on KOSDAQ in 2018. The company produces metal and biomaterial-based implants across all orthopedic fields, supplying medical devices for the fixation, replacement, and adjustment of fractured bones. It has secured vertically integrated process technology, collaborates with B. Braun, and is pursuing FDA and CE approvals to expand into global markets. Osteonick is headquartered in Guro-gu, Seoul.